Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
On May 22, 2026, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
On May 20, 2026, Engage Biologics, a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it…
On May 19, 2026, Colossal Biosciences announced it is developing a functional artificial womb capable of growing a…
On May 19, 2026, Colossal Biosciences announced their artificial egg — a silicone-membrane synthetic shell system — successfully…
On May 17, 2026, the Director-General of the World Health Organization (WHO) announced that the Ebola disease caused…
On May 15, 2026, PolyU Science researchers have pioneered a method that uses engineered proteins to store digital…
On May 15, 2026, The World Health Organization (WHO) announced it is rapidly scaling up support to the…
On May 12, 2026, Stanford University announced a $90 million gift from Penny and Philip H. Knight, MBA…
On May 12, 2026, Bristol Myers Squibb and Hengrui Pharma announced the companies have entered into global strategic…
On May 11, 2026, Fujirebio Europe announced that it has obtained a CE certificate of the Lumipulse G…
On May 8, 2026, researchers detected infectious H5N1 virus in milking parlor air and wastewater systems while also…
On May 7, 2026, Angelini Pharma and Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and…
On May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research…
On May 6, 2026, Eli Lilly announced an additional $4.5 billion investment across two of its three Lebanon…
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
On May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI…
On May 4, 2026, a study conducted by the University of Geneva and the Lausanne University Hospital (CHUV)…
On May 3, 2026, UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it…
On May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other…
On Apr. 30, 2026, researchers at the University of Bonn and University Hospital Bonn have created a groundbreaking…
On Apr. 30, 2026, Colossal Biosciences, the world’s de-extinction company, announced that it is working to de-extinct the…
On Apr. 29, 2026, Dr. Reddy’s Laboratories announced that it has received a Notice of Compliance (NOC) from…
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
On Apr. 28, 2026, scientists Sandeep (Robert) Datta, professor of neurobiology in the Blavatnik Institute at Harvard Medical…
On Apr. 28, 2026, new research from the Mayo Clinic show subtle biological changes linked to Alzheimer’s disease…
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
On Apr. 27, 2026, Sun Pharmaceutical Industries and Organon announced they have entered into an agreement under which…
On Apr. 24, 2026, researchers at Princeton University announce they have developed a 3-dimensional device that merges living…
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
On Apr. 23, 2026, a research team at the University College London (UCL) and Great Ormond Street Hospital…